SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-18-007732
Filing Date
2018-07-16
Accepted
2018-07-16 17:25:26
Documents
3
Period of Report
2018-05-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT qbio10q.htm 10-Q 494219
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit31.htm EX-31.1 19337
3 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE exhibit32.htm EX-32.1 8199
  Complete submission text file 0001654954-18-007732.txt   522859
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 000-55535 | Film No.: 18955075
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences